Latest Articles

  • Anemia of chronic kidney disease: Treat it, but not too aggressively
    Anemia of chronic kidney disease: Treat it, but not too aggressively
    Georges Nakhoul, MD and James F. Simon, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 613-624; DOI: https://doi.org/10.3949/ccjm.83a.15065

    Renal anemia is associated with bad outcomes, but attempting to normalize hemoglobin levels can be harmful.

  • Advanced-stage calciphylaxis: Think before you punch
    Arsha Sreedhar, MD, Hina A. Sheikh, MD, Charles J. Scagliotti, MD, FACS and Ranjit Nair, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 562-564; DOI: https://doi.org/10.3949/ccjm.83a.15103

    Biopsy can cause or worsen ulceration at the incision site, increasing the risk of infection and sepsis.

  • In reply: Prescribing opioids (March 2016)
    Daniel G. Tobin, MD, FACP, Rebecca Andrews, MD, FACP and William C. Becker, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 554-555; DOI: https://doi.org/10.3949/ccjm.83c.08002
  • Is a serum TSH measurement sufficient to monitor the treatment of primary hypothyroidism?
    Christian Nasr, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 571-573; DOI: https://doi.org/10.3949/ccjm.83a.15165

    Yes, the TSH level provides the information you need to manage primary hypothyroidism.

  • Acute liver failure (June 2016)
    Howard Homler, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 557; DOI: https://doi.org/10.3949/ccjm.83c.08005

    Readers comment on managing acute liver failure (June 2016)

  • Your patient has chronic leukemia: Now what?
    Matt Kalaycio, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 575-581; DOI: https://doi.org/10.3949/ccjm.83gr.16002

    New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.

  • Should patients with stable ischemic heart disease undergo revascularization?
    Michael Chenier, MD, MPH and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 567-570; DOI: https://doi.org/10.3949/ccjm.83a.15093

    The benefi t is much less clear for stable disease than for acute coronary syndromes.

  • Renal failure in HCV cirrhosis
    Chitra Deepak Punjabi, MD, Yu Kuang Lai, MD, Manjula Balasubramanian, MD and Imara Dissanayake, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 583-588; DOI: https://doi.org/10.3949/ccjm.83a.15106

    The patient was diagnosed with hepatitis C 15 years ago; now, his kidneys are failing.

  • Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Heesun J. Rogers, MD, PhD, Charles Allen, DO and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 597-603; DOI: https://doi.org/10.3949/ccjm.83a.15009

    ADAMTS13 testing is useful in diagnosing this disease, guiding therapy, and predicting relapse.

  • Geographic tongue
    Ceena Neena Jacob, MD, Teny Mathew John, MD, DNB and R. Jayaprakash, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 565-566; DOI: https://doi.org/10.3949/ccjm.83a.14011

    Although striking, the lesion is benign and self-limiting and rarely warrants further investigation.

Pages